Arkolith/Insider Trading/ATHA/Form 4

Worthington Mark

General Counsel and CCOAthira Pharma, Inc. (ATHA) · full profile →Form 4 · filed Jan 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2025Sell(S)9K$0.56$5K84K
Dec 31, 2024Option exercise(M)37K—$092K
Nov 18, 2024Grant(A)4K$0.55$2K56K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2024Option exercise(M)37K—$073K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-000525) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML